Alterity Therapeutics Limited | PRAN - Operating Profit


Alterity Therapeutics Limited reported AUD-7.77M in Operating Profit for its fiscal semester ending in June of 2023.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Arca Biopharma USD -25.09M 5.23M Mar/2025
aTyr Pharma USD -26.74M 6.43M Sep/2025
Bio Path USD -3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD -3.09M 100K Mar/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025
Cara Therapeutics USD -2.39M 3.49M Mar/2025
CSL USD 2.64B 1.97B Dec/2025
Esperion Therapeutics USD -16.03M 18.6M Sep/2024
Immunic USD -25.73M 2.91M Sep/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Insmed USD -249.71M 11.64M Dec/2025
Minerva Neurosciences USD -21.85M 17.48M Dec/2024
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
TherapeuticsMD USD -1.18M 40K Jun/2024